FDA Issues First Untitled Letter of the Year to HCT/P Manufacturer | Sheppard Mullin Richter & Hampton LLP
On March 1, 2023, the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA) published its first untitled letter of the year to Thomas...
Public Health Service Sheppard Mullin Richter Hampton Thomas Advanced Medical Drug Administration Drug Administration Staff Sheppard Mullin Richter
Source: jdsupra.com